Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels

DPP-4 Inhibitors: Impact on glycemic control and cardiovascular risk factors

(2011) D. Dicker   DIABETES CARE

The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes

(2011) Hajime Maeda et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Contributing factors related to efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes

(2011) Takashi Nomiyama et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials

(2011) Matteo Monami et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus

(2010) et al.   Journal of Diabetes Investigation

GIP and GLP-1, the two incretin hormones: Similarities and differences

(2010) Yutaka Seino et al.   Journal of Diabetes Investigation

Prevention of insulin resistance by n-3 polyunsaturated fatty acids

(2009) Dawn Fedor et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Usefulness of colon targeted DHA and EPA as novel diabetes medications that promote intrinsic GLP-1 secretion

(2008) Mariko Morishita et al.   JOURNAL OF CONTROLLED RELEASE